{
    "title": "Russian firm gets approval for drug said to block coronavirus replication",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8503331/Russian-firm-gets-approval-drug-said-block-coronavirus-replication.html",
    "date": "2020-07-08",
    "keywords": [
        "drug",
        "coronavir",
        "treatment",
        "russia",
        "rpharm",
        "coronavirus",
        "avifavir",
        "use",
        "wednesday",
        "replication",
        "statement",
        "study",
        "day",
        "ministry",
        "developer",
        "tally",
        "trial",
        "mild",
        "mediumlevel",
        "world",
        "sarscov2",
        "virus",
        "companys",
        "improvement",
        "etiotropic",
        "therapy",
        "cause",
        "difference",
        "practice",
        "stop",
        "infection",
        "result",
        "obstruction",
        "mikhail",
        "samsonov",
        "director",
        "head",
        "research",
        "institute",
        "epidemiology",
        "ryzhentsova",
        "june",
        "health",
        "approval",
        "process",
        "period",
        "way",
        "rdif",
        "sovereign",
        "wealth",
        "fund",
        "backing",
        "covid19",
        "home",
        "month",
        "hospital",
        "illness",
        "case",
        "writing",
        "polina",
        "kevin",
        "liffey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}